Soleno Therapeutics Inc (SLNO)

Stock price, financials, and technical signals for Soleno Therapeutics Inc (SLNO).

$49.03

2.33

(4.99%)

As of 03/13/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

SLNO Performance Snapshot


1-Week Chg

9.10%

1-Month Chg

-4.48%

3-Month Chg

4.97%

6-Month Chg

-7.21%

1-Year Chg

11.48%

Year-To-Date Chg

7.26%

Beta 1-Year

0.87

Beta 5-Year

-2.42

Volatility (10-Day)

3.79%

SLNO Technicals



SLNO Financials


Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE


  • Cash and equivalents

    $87.93M

    -48.18%

  • Total assets

    $330.97M

    83.17%

  • Total liabilities

    $85.86M

    270.34%

  • Total investments

    $230.72M

    -

  • Shareholders' equity

    $245.11M

    55.62%

  • Book value per share

    $5.58

    -41.60%


Income Statement

(USD)

2024 Q4

Y/Y CHANGE


  • Revenue

    $0

    0%

  • Net income

    -$55.98M

    -395.59%

  • Operating expense

    $58.79M

    358.25%

  • Gross profit

    $0

    0%

  • EBITDA

    -$55.05M

    -412.61%

  • Earnings per share

    -$1.30

    -548.28%


Cash Flow

(USD)

2024 Q4

Y/Y CHANGE


  • Net change in cash

    $39.52M

    -66.30%

  • Cash from operations

    -$23.99M

    -279.97%

  • Cash from investing

    $6.44M

    -

  • Cash from financing

    $57.06M

    -53.82%

  • Free cash flow

    -$24.00M

    -280.09%

  • Free cash flow per share

    -$0.55

    -42.56%


Metrics

(USD)

2024 Q4

Y/Y CHANGE


  • Market capitalization

    $1.94B

    57.88%

  • Enterprise value

    $1.89B

    61.00%

  • Shares outstanding

    43.12M

    41.37%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q4

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    15.68

    5.26%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.